Search Results for 'Empaglifozin Placebo'

MM McDermott and coauthors

• debby-jeon
• 0 Slides

Effect of Granulocyte-Macrophage Colony-Stimulati...

New Antiepileptic Medications

• conchita-marotz
• 0 Slides

. Drug Profiles, Efficacy, Safety, and Tolerabil...

Autoimmune and chronic cholestatic

• tatyana-admore
• 0 Slides

liver disease. Best of ILC 2018. About these slid...

Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

• olivia-moreira
• 67 Slides

Jointly provided by ...

The Impending D eath of Cancer: A Herculean Task Emerging Therapies 2016

• phoebe-click
• 33 Slides

The Impending D eath of Cancer: A Herculean Task...

Ezra W Cohen University of California, San Diego

• natalia-silvester
• 76 Slides

Ezra W Cohen University of California, San Diego...

ADVANCED PROSTATE CANCER: BONE ISSUES AND METASTASES

• min-jolicoeur
• 58 Slides

ADVANCED PROSTATE CANCER: BONE ISSUES AND METASTA...

Ru -Band Lu, MD . Shiou-Lan

• conchita-marotz
• 44 Slides

Ru -Band Lu, MD . Shiou-Lan Chen, PhD . Yun-Hsua...

The Effects of Cannabis and Alcohol

• mitsue-stanley
• 15 Slides

The Effects of Cannabis and Alcohol on Driving P...

PCSK-9 Inhibitors Paul J

• tatyana-admore
• 52 Slides

PCSK-9 Inhibitors Paul J Kovack , DO, FACC, FACO...

Peter S. Sever* ,

• alida-meadow
• 20 Slides

Peter S. Sever* , Choon L. Chang, Ajay Gupta, ...

Case Scenario #1 Luis is a 9-year-old male seen in clinic with a complaint of worsening pruritus causing difficulties in school and sleep.

• conchita-marotz
• 63 Slides

Case Scenario #1 Luis is a 9-year-old male seen i...

THE CAUSES AND CURES OF SCURVY.

• sherrill-nordquist
• 15 Slides

THE CAUSES AND CURES OF SCURVY. HOW MODERN WAS JA...

PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo

• tawny-fly
• 7 Slides

Post-Menopausal Women with Hormone-Receptor Posit...

AHCCCS Pharmacy and Therapeutics Committee

• min-jolicoeur
• 162 Slides

16 October 2019. Welcome and Introductions. Sara...

Application of the Data:

• giovanna-bartolotta
• 38 Slides

Cardiometabolic Disease Is an Epidemic. Clinical ...

Psychiatric Medications

• carneos
• 151 Slides

and. Child Welfare. Terry Lee, MD. drterry@uw.edu....

Management of Alcoholic Hepatitis

• friendma
• 23 Slides

and Cirrhosis. W. Ray Kim, MD. Gastroenterology an...

Journal Club 埼玉医科大学　総合医療センター　内分泌・糖尿病内科

• hondasnoopy
• 19 Slides

Department of Endocrinology and Diabetes, . Saitam...

Please note, these are the actual video-recorded

• chaptoe
• 71 Slides

proceedings from the live CME event and may includ...

Towards ending the AIDS Epidemic: Progress and Evidence

• shoulderheinz
• 25 Slides

Willard . Tinago. , . PhD. HIV . Molecular Researc...

Protecting the heart and the kidney:

• pressio
• 38 Slides

Implications from the SHARP trial. Dr. Christina R...

LDL Cholesterol Lowering with

• shoffer
• 18 Slides

Evolocumab. and Outcomes in Patients with . Perip...

La depressione nelle malattie neurologiche

• maniakiali
• 62 Slides

Roberto Ceravolo,. Department of Clinical and Expe...

Authors: Sheila T. Lim, M.D.1 Cecilia A.

• coveurit
• 23 Slides

Jimeno. , M.D.2 . Elvie. B. Razon-Gonzales, M.D. ...

How to Model Different Dose-effects

• jezebelfox
• 30 Slides

in . Networks . of . Interventions. ?. Areti . Ang...

Innovations in HIV Prevention Research

• numeroenergy
• 22 Slides

:. Novel adherence and diagnostic technologies. Cr...

Progress in the HIV Vaccine Field

• eatsui
• 67 Slides

Larry Corey, MD. Principal Investigator, NIAID sup...

Health and the Gut Microbiome:

• collectmcdonalds
• 48 Slides

Restoring a Lost . L. egacy. Mark Pettus MD. Direc...

Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f

• dsuser1
• 100 Slides

www.onlinecjc.com. ).  . If your reuse request qu...

New Drugs The Good, The Bad,

• loaiatdog
• 66 Slides

and the Worthless. Bill Origer MD. OAFP 2015. Disc...

Tratamentul farmacologic in

• reportperfect
• 23 Slides

jocul de noroc patologic. Cocea. . Eduard-. Natan...

T icagrelor W ith Asp I

• terrificycre
• 47 Slides

rin or A. L. one . I. n Hi. GH. -Risk Patients Aft...

• clustik
• 52 Slides

proceedings from the live CME event and may includ...

End-Points and Rationale for Phase III Trials in HCC: Adjuvant, Intermediate, and Advanced HCC

• maniakti
• 43 Slides

Richard S. Finn, MD. Professor of Clinical Medicin...

• billiontins
• 108 Slides

2018;36(8):773-9.. Nivolumab Monotherapy (Cohort 1...

Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights from the EXSCEL Trial

• relylancome
• 19 Slides

Robert J. Mentz, M. Angelyn Bethel, Peter Merrill,...

• medshair
• 44 Slides

Five-year . survival. 15%. 30%. 40%. ?50%?. First ...

Osteoclast Inhibitors in Malignancy

• onionchevrolet
• 57 Slides

Joel Brothers. 10/4/2016. Understand the indicatio...

M.W. Fried , 1 M. Buti,

• iamamercy
• 18 Slides

2. G.J. Dore,. 3. P. Ferenci,. 4. . I. Jacobson...